Cargando…
Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey
BACKGROUND: Despite their limited licensed indications, anti–interleukin-1 (anti–IL-1) agents are often used in clinical practice for an increasing number of auto-inflammatory diseases. We conducted a national cross-sectional observational study from January 2011 to January 2013 to record the off-la...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340831/ https://www.ncbi.nlm.nih.gov/pubmed/25758134 http://dx.doi.org/10.1186/s13023-015-0228-7 |